The Lancet Commission on prostate cancer: planning for the surge in cases.
- DOI
- 10.1016/s0140-6736(24)00651-2
- Published
- 2024 Apr 27
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-24-00651-2,
title = {The Lancet Commission on prostate cancer: planning for the surge in cases.},
author = {James ND and Tannock I and N'Dow J and Feng F and Gillessen S and Ali SA and Trujillo B and Al-Lazikani B and Attard G and Bray F and Compérat E and Eeles R and Fatiregun O and Grist E and Halabi S and Haran Á and Herchenhorn D and Hofman MS and Jalloh M and Loeb S and MacNair A and Mahal B and Mendes L and Moghul M and Moore C and Morgans A and Morris M and Murphy D and Murthy V and Nguyen PL and Padhani A and Parker C and Rush H and Sculpher M and Soule H and Sydes MR and Tilki D and Tunariu N and Villanti P and Xie LP},
year = {2024},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(24)00651-2},
url = {https://doi.org/10.1016/s0140-6736(24)00651-2}
}RIS
TY - JOUR TI - The Lancet Commission on prostate cancer: planning for the surge in cases. AU - James ND AU - Tannock I AU - N'Dow J AU - Feng F AU - Gillessen S AU - Ali SA AU - Trujillo B AU - Al-Lazikani B AU - Attard G AU - Bray F AU - Compérat E AU - Eeles R AU - Fatiregun O AU - Grist E AU - Halabi S AU - Haran Á AU - Herchenhorn D AU - Hofman MS AU - Jalloh M AU - Loeb S AU - MacNair A AU - Mahal B AU - Mendes L AU - Moghul M AU - Moore C AU - Morgans A AU - Morris M AU - Murphy D AU - Murthy V AU - Nguyen PL AU - Padhani A AU - Parker C AU - Rush H AU - Sculpher M AU - Soule H AU - Sydes MR AU - Tilki D AU - Tunariu N AU - Villanti P AU - Xie LP PY - 2024 JO - Lancet (London, England) DO - 10.1016/s0140-6736(24)00651-2 UR - https://doi.org/10.1016/s0140-6736(24)00651-2 ER -
APA
ND, J., I, T., J, N., F, F., S, G., SA, A., B, T., B, A., G, A., F, B., E, C., R, E., O, F., E, G., S, H., Á, H., D, H., MS, H., M, J., S, L., A, M., B, M., L, M., M, M., C, M., A, M., M, M., D, M., V, M., PL, N., A, P., C, P., H, R., M, S., H, S., MR, S., D, T., N, T., P, V., & LP, X. (2024). The Lancet Commission on prostate cancer: planning for the surge in cases.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)00651-2
Source records
- pubmed · retrieved 2026-09-26T12:27:13.980Z